These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 7140136)
1. Comparison of intravenous and oral verapamil dosing. Reiter MJ; Shand DG; Pritchett EL Clin Pharmacol Ther; 1982 Dec; 32(6):711-20. PubMed ID: 7140136 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of verapamil: experience with a sustained intravenous infusion regimen. Reiter MJ; Shand DG; Aanonsen LM; Wagoner R; McCarthy E; Pritchett EL Am J Cardiol; 1982 Oct; 50(4):716-21. PubMed ID: 7124631 [TBL] [Abstract][Full Text] [Related]
3. Prediction of steady-state verapamil plasma concentrations in children and adults. Wagner JG; Rocchini AP; Vasiliades J Clin Pharmacol Ther; 1982 Aug; 32(2):172-81. PubMed ID: 7094504 [TBL] [Abstract][Full Text] [Related]
4. R-verapamil: pharmacokinetics and effects on PR interval, blood pressure and heart rate. Ahmed JH; Godden J; Meredith PA; Elliott HL Br J Clin Pharmacol; 1993 Aug; 36(2):93-8. PubMed ID: 8398588 [TBL] [Abstract][Full Text] [Related]
5. The pharmacology of verapamil. IV. Kinetic and dynamic effects after single intravenous and oral doses. McAllister RG; Kirsten EB Clin Pharmacol Ther; 1982 Apr; 31(4):418-26. PubMed ID: 7060323 [TBL] [Abstract][Full Text] [Related]
6. Effects of d,l-verapamil on atrioventricular conduction in relation to its stereoselective first-pass metabolism. Echizen H; Vogelgesang B; Eichelbaum M Clin Pharmacol Ther; 1985 Jul; 38(1):71-6. PubMed ID: 4006378 [TBL] [Abstract][Full Text] [Related]
7. Verapamil disposition and cardiovascular effects in elderly patients after single intravenous and oral doses. Carosella L; Menichelli P; Alimenti M; Zuccala G; Gemma A; Cocchi A; Carbonin PU Cardiovasc Drugs Ther; 1989 Jun; 3(3):417-25. PubMed ID: 2487538 [TBL] [Abstract][Full Text] [Related]
9. Effects of verapamil on P-R-intervals in relation to verapamil plasma levels following single I.V. and oral administration and during chronic treatment. Eichelbaum M; Birkel P; Grube E; Gütgemann U; Somogyi A Klin Wochenschr; 1980 Sep; 58(18):919-25. PubMed ID: 7206587 [TBL] [Abstract][Full Text] [Related]
10. The pharmacology of verapamil. I. Elimination kinetics in dogs and correlation of plasma levels with effect on the eletrocardiogram. McAllister RG; Bourne DW; Dittert LW J Pharmacol Exp Ther; 1977 Jul; 202(1):38-44. PubMed ID: 874818 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of two formulations of verapamil. Hla KK; Henry JA; Latham AN Br J Clin Pharmacol; 1987 Nov; 24(5):661-4. PubMed ID: 3435694 [TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic profile of verapamil in relation to absolute bioavailability: investigations with a conventional and a controlled-release formulation. Harder S; Thürmann P; Siewert M; Blume H; Huber T; Rietbrock N J Cardiovasc Pharmacol; 1991 Feb; 17(2):207-12. PubMed ID: 1709224 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of verapamil following sublingual and oral administration to healthy volunteers. John DN; Fort S; Lewis MJ; Luscombe DK Br J Clin Pharmacol; 1992 Jun; 33(6):623-7. PubMed ID: 1389935 [TBL] [Abstract][Full Text] [Related]
14. Impact of food on the pharmacokinetics and electrocardiographic effects of sustained release verapamil in normal subjects. Hoon TJ; McCollam PL; Beckman KJ; Hariman RJ; Bauman JL Am J Cardiol; 1992 Oct; 70(11):1072-6. PubMed ID: 1414906 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the pharmacokinetics and electrocardiographic effects of sublingual and intravenous verapamil. Berk SI; Beckman K; Hoon TJ; Hariman RJ; Hu D; Siegel FP; Bauman JL Pharmacotherapy; 1992; 12(1):33-9. PubMed ID: 1549537 [TBL] [Abstract][Full Text] [Related]